Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
ELISA OYJ | ELISA | Nasdaq Helsinki +6 Other | 294,658 | 42.7 EUR | Stock | |
ELISA OYJ | EIA | Deutsche Boerse AG | 24 | 42 EUR | ||
ELISA OYJ | 0I8Y | London S.E. | - | 42.65 EUR | ||
ELISA OYJ | EIA | Börse Stuttgart | - | 42.24 EUR | ||
ELISA OYJ | EIA | BOERSE MUENCHEN | - | 42.8 EUR | ||
ELISA OYJ | ELMUF | OTC Markets | 851 | 45.16 USD | ||
ELISA OYJ | EIA | Berne S.E. | - | - CHF | ||
ELISA OYJ | ELMUY | OTC Markets | 1,593 | 24 USD | Stock | |
ELISA OYJ (EI6) - ELA/C5 | Euronext Amsterdam | - | 42.18 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C6 | Euronext Amsterdam | - | 42.53 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C2 | Euronext Amsterdam | - | 42.56 EUR | Future | ||
ELISA OYJ (EI6) - ELA/20241220 | Euronext Amsterdam | - | 42.47 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C1 | Euronext Amsterdam | - | 42.4 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C3 | Euronext Amsterdam | - | 42.64 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C4 | Euronext Amsterdam | - | 42.92 EUR | Future | ||
ELISA OYJ (EI6) - ELA/20240620 | Euronext Amsterdam | - | 42.8 EUR | Future |
News (6)
Companies (18)
Beijing Wantai Biopharmaceutical Co., Ltd. is a company mainly engaged in the research and development, production and sales of in-vitro diagnostics. The Company produces and sells in-vitro diagnostics, in-vitro diagnostic equipment and vaccines. The Comp ...
Elisa Oyj is the No. 1 private telecommunications company in Finland. Net sales break down by activity as follows: - mobile telephone service (59.2%); - fixed telecommunication (40.8%): fixed telephone service and broadband Internet access, TV broadcast ...
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is a Turkey-based company engaged in the research, development and production of in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media ...
Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Companyâs portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test ...
Soprocal Calerias e Industrias SA is a Chile-based company engaged in the acquisition and exploitation of mineral deposits as well as the production of calcium carbonate, quicklime, lime off, hydraulic lime, as well as other related derivatives. As of Dec ...
Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa det ...
AroCell publ AB is a Sweden-based diagnostic Company engaged in the development of markers for determination of cell growth (TK 210) and apoptosis. The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood c ...
Cheilbio Co., Ltd. is a Korea-based company engaged in the manufacturing of veterinary drugs. The Company's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, ...
American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of ...
1000mercis specializes in providing interactive advertising and marketing services. Net sales break down by activity as follows: - interactive marketing services (45.2%): develops market segment studies and satisfaction questionnaires, processes collecte ...
Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, sales and provision of food safety testing products and related services. The Companyâs main products are food safety rapid testing r ...
Aptamer Group plc is a United Kingdom-based company that develops custom affinity binders through its Optimer platform to enable new approaches in therapeutics, diagnostics and research applications. The Company's Optimer platform delivers next-generation ...
Bioventix plc is a United Kingdom-based company specializing in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, such as in automated immunoassays used in blood testing. The antibodies ...
Bioqual, Inc. is engaged in performing contract research services, which is focused on in vivo models of human diseases, including COVID-19, acquired immune deficiency syndrome (AIDS), influenza, Mpox, respiratory syncytial virus (RSV) infection, Flavivir ...
Spring Art Holdings Berhad is a Malaysia-based investment holding company. The Company, through its subsidiary, Spring Art Industries Sdn. Bhd., is principally involved in the manufacturing of ready-to-assemble furniture products, where it undertakes the ...
ViroGates A/S is a Denmark-based medical technology company. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflect ...
Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its ca ...
Techlab Inc. (Techlab) is a medical device diagnostic product manufacturer. The Company develops and manufactures intestinal diagnostics worldwide. Techlab manufactures a variety of in vitro enteric diagnostics to determine Clostridium difficile, Escheric ...
Insiders
Currently, Elisa Patrizi occupies the position of Head-Operations & Maintenance at Infrastrutture Wireless Italiane SpA. In the past Ms. Patrizi was Manager-Wireless Development at Telecom Italia SpA. She received an undergraduate degree from Università degli Studi di Roma Tor Vergata.
Tony Marco Patrizi is the founder of GR Engineering Services Ltd., a company he founded in 2006.
He currently holds the title of Managing Director & Executive Director at the firm.
In addition to his founding position, Mr. Patrizi has also held former positions.
From 2016 to 2018, he served as an Independent Non-Executive Director at Primary Gold Ltd.
He also worked as an Operations Manager at JR Engineering Services Pty Ltd.
Marco Anselmo Patrizi currently works at Morison KSi Ltd., as Director.
Scott Patrizi is a professional with experience in various non-executive director roles.
He is currently a Non-Executive Director at Forrestania Resources Ltd.
Prior to this, he was the President, Chief Executive Officer & Director at Huntsman Exploration, Inc. from 2021 to 2023.
He also served as a Non-Executive Director at Elixir Energy Ltd.
from 2016 to 2019, and at Rarex Ltd.
from 2016 to 2020.
Additionally, he briefly served as a Non-Executive Director at Caprice Resources Ltd.
in 2021.
Patrizi holds an undergraduate degree from The University of Western Australia Business School.
Elisa currently works at PT Metro Healthcare Indonesia Tbk, as Manager-Finance & Accounting.
Elisa Massimino is a Trustee at the McCain Institute for International Leadership.
Previously, she served as the President & Chief Executive Officer at Human Rights First.
Elisa Coletti is an economist who currently works at Intesa Sanpaolo.
SpA (Broker) as an Economist Banks.
Elisa Burns has been a Trustee at Northern Westchester Hospital Association since 2013.
Dr. Elisa Newby is an Economist at Bank of Finland.
Her current areas of responsibility include preparation of the Bank of Finland’s macroeconomic forecasts and development of forecasting systems and models.
Prior to this she has worked as a lecturer at the University of Cambridge and a researcher at the Centre for Dynamic Macroeconomic Analysis (CDMA) at the University of St Andrews in Scotland.
In 2002–2004, Dr. Newby worked in the Bank of Finland’s Statistics Department, where she was responsible for compiling balance of payments statistics.
In 1999–2002, she served as a derivatives expert on the Helsinki Stock Exchange.
Dr. Newby completed her PhD in Economics at the CDMA in 2007.
Her doctoral dissertation dealt with sustainable monetary policy.
She also has a Master’s degree in Social Sciences from the University of Helsinki.
Elisa Rusu worked at Banca Transilvania SA from 2009 to 2017 as a Manager in the Factoring Department.
Elisa M.
Wilson is currently serving as an Independent Non-Executive Director at GAMCO Investors, Inc. since 2009.
She is also a Director at GGCP, Inc., Associated Capital Group, Inc., and the American Red Cross of Greater New York.
Additionally, she holds positions as a Director at the Breast Cancer Alliance, Member-BPA Board at Brunswick School, Inc., and Trustee at Boston College.
Ms. Wilson has been the President & Trustee of the Gabelli Foundation, Inc. since 2009.
In terms of education, she has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Boston College.
Elisa Perillo worked as a Principal at Umbrella SRL.
She obtained an undergraduate degree from the University of Padua in 2003.
Ms. Elisa Brizuela is a Senior Equity Trader at Segall Bryant & Hamill LLC.
Ms. Brizuela is responsible for Segall Bryant & Hamill's Small Cap Equity trading, as well as assisting institutional equity trading.
She has been in the investment industry since 1987.
Prior to joining the firm, she was an international equity trader at Driehaus Capital Management and William Blair Asset Management.
Ms. Elisa Dannemiller is Chief Medical Officer at Sharklet Technologies, Inc. and a Member at American College of Emergency Physicians.
Ms. Dannemiller was previously employed as a Principal by McKinsey & Co., Inc. She also served on the board at The Denver Business Series.
She received her undergraduate degree from the University of Virginia.
Elisa Nunes has worked as a consultant at Invicta Angels SGPS SA since 2012.
Elisa Pascal has a current job as the Head of Shareholder Relations at Edenred SE.
Elisa Magro is the founder of The Amazing Food Co. Srl, which was founded in 2011.
Ms. Elisa Machado is a Senior Economist at ARX Investimentos Ltda.
She was previously employed as Economist by Aria Capital, Economic Consultant by Atico Administração de Recursos Ltda., Economist by Icatu Gestão Patrimonial Ltda., Opus Gestão de Recursos Ltda., FUNCEX - Foreign Trade Studies Center Foundation and Bank of America, Consultnat by CBIE – Brazilian Center of Infrastructure, Researcher by IPEA - Institute for Applied Economic Research and Lecturer by PUC-Rio (1996) and Ibmec (2000).
Ms. Machado holds a degree in Economics from Universidade Federal Fluminense and Master's in Economics from Pontifícia Universidade Católica do Rio de Janeiro.
Elisa Waldeck is a Member of The Institute of Directors, her current job.
In the past, she worked as a Secretary at Blue Financial Services Ltd.
from 2011 to 2012.
Elisa Rizza Trelewicz is currently working as Vice President & Senior Securities Analyst at Columbus Circle Investors since 2001.
She completed her undergraduate degree from the University of Connecticut in 2000.
Elisa Jagerson is a Managing Director at Wildcat where she focuses on investments in Climate Tech SaaS solutions that reduce the effects of climate change.
Her specific areas of interest include AI and Machine Learning (ML) enabled platforms that create disruptive levels of foresight into a future perceived to be unpredictable.
Elisa was most recently CEO of FutureBrand Speck, best known for driving product and service innovation to both market disrupters and industry leaders.
Organizations turned to Elisa and her teams of brand, product, environment and service designers when they needed to accelerate or ‘future proof’ growth.
These products sit today inside our pockets, bodies, hospitals, cars, and data centers, and have generated billions in revenue.
After pioneering ‘experience engineering’, a next generation design thinking methodology credited with infusing reliability into the innovation process, Elisa sold Speck Design to FutureBrand (NYSE: IPG), where she then served on the global leadership team.
Earlier in her career as Founder and CEO of PartsRiver, Elisa pioneered early intelligent data management (IDM) in the transportation industry.
There she acquired $150M in assets from Saqqara and CDC (a Boeing subsidiary), growing PartsRiver into the leading provider of IDM.
Following her success at PartsRiver, Elisa launched and ran Bay Laurel Capital, a micro-cap leveraged buyout firm affiliated with AI LLC.
Elisa began her finance career in global emerging markets, making investments at New York-based private equity firm Zephyr Management and Harare-based ZPF.
Elisa received a BA Cum Laude from Princeton University and an MBA from the Wharton School of Business.
Elisa Dozono currently works as a Director at Oregon Public Broadcasting.
No results for this search
- Stock Market
- Advanced search
- Elisa Patrizi